Heterogeneous point mutations of the p53 gene in pulmonary fibrosis

European Respiratory Journal

Volumn 12, Issue 6, 1998, Pages 1404-1408

  Hojo, S ^a   Fujita, J ^a   Yamadori, I ^b   Kamei, T ^c   Yoshinouchi, T ^d   Ohtsuki, Y ^e   Okada, H ^a   Bandoh, S ^a   Yamaji, Y ^a   Takahara, J ^a   Fukui, T ^f   Kinoshita, M ^f  

^a KAGAWA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d Matsuyama Rehabilitation Hospital   (Japan)

^e KOCHI MEDICAL SCHOOL   (Japan)

^f Otsuka Assay Laboratories   (Japan)

Author keywords

Bronchoepithelial cells; Idiopathic pulmonary fibrosis; Lung cancer; p53; Point mutations

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DNA DAMAGE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; LUNG FIBROSIS; MALE; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; POINT MUTATION; PRECANCER; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; AGED; FEMALE; GENES, P53; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PRECANCEROUS CONDITIONS; PULMONARY FIBROSIS;

EID: 0032427870     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12061404     Document Type: Article

References (15)

1. Nagai A, Chiyotani A, Nakadate T, Konno K. Lung cancer in patients with idiopathic pulmonary fibrosis. Tohoku J Exp Med 1992; 167: 231-237.
2. Furihata M, Sonobe H, Ohtsuki Y. The aberrant p53 protein (Review). Int J Oncol 1995; 6: 1209-1226.
3. Wafl.Cipl/Sdil and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1996; 154: 477-483.
4. Katsuragi K, Chiba W, Matsubara Y, Ikeda S, Ueta C, Kinoshita M, A sensitive and high-resolution method for the detection of mutations in the p53 gene using fluorescence-based PCR-SSCP. Biomed Res 1995; 16: 273-279.
5. Carson DA, Lois A. Cancer progression and p53. Lancet 1995; 346: 1009-1011.
6. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
7. Harris CC, Hollstein M. Clinical implications of the p53 tumor suppressor gene. N EngI J Med 1993; 329: 1318-1327.
8. Vahakangas KH, Samet JM, Metcalf RA, et al. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 1992; 339: 576-580.
9. Sozzi G, Miozzo M, Donghi R, et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 1992; 52: 6079-6082.
10. Mizushima Y, Kobayashi M. Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis. A review of Japanese cases. Chest 1995; 108: 1272-1277.
11. Nees M, Homann N, Discher H, et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res 1993; 53: 4189-4196.
12. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-879.
13. Wu JK,Ye Z, Darras BT. Sensitivity of single-strand conformation polymorphism (SSCP) analysis in detecting p53 point mutations in tumors with mixed cell populations. Am J Hum Genet 1993; 52: 1273-1275.
14. Tindall KR, Kunkel TA. Fidelity of DNA synthesis by the Thermus aquaticus DNA polymerase. Biochemistry 1988; 27: 6008-6013.
15. Sundaresan V, Ganly P, Hasleton P, et al. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 1992; 7: 1989-1997.